Organization
Shire Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Shire Plc
... admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting ...
... such as rFurin, CHO-protein or mouse IgG developed after treatment with rVWF.4 'Shire has a long heritage in hematology and we are committed to developing ...
... Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company') announces that Olivier Bohuon, Senior Independent ...
... (GlobeNewswire) - Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology New ...
... for $67 billion. ? Japan's Takeda is scooping up rival pharmaceutical company Shire for $62 billion. ? German utility E.On announced it would purchase green ...
... Takeda's $62 billion acquisition of Shire will vault it into the 10 pharma companies worldwide, but will also ...
... Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology - ...
... their 2025 sales prediction at $5 billion. RELATED: New Roche threat to Shire's hemophilia franchise? CEO Ornskov says he's not worried Investors are expecting big ...
... admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting ...
... in Massachusetts or with significant operations here, including pharmaceutical giants Biogen and Shire. Biogen was reported to the FDA by a generic-producing company for issues ...
Subscribe now for full coverage on Shire Plc
Start My Free Trial